Disruption of differentiation in human cancer: AML shows the way
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Although much is understood about the ways in which transcription factors regulate various differentiation systems, and one of the hallmarks of many human cancers is a lack of cellular differentiation, relatively few reports have linked these two processes. Recent studies of acute myeloid leukaemia (AML), however, have indicated how disruption of transcription-factor function can disrupt normal cellular differentiation and lead to cancer. This model involves lineage-specific transcription factors, which are involved in normal haematopoietic differentiation. These factors are often targeted in AML--either by direct mutation or by interference from translocation proteins. Uncovering these underlying pathways will improve the diagnosis and treatment of AML, and provide a working model for other types of human cancer, including solid tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autoregulation may be a common feature of several transcriptional regulators to augment the relatively irreversible nature of differentiation processes in the hematopoietic system (60,61).”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [60]
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864 · cited 1×
“What is the role of lineage-specific transcription factors on stem cells, and how does this relate to AML? Although most of the blast cells from patients with AML clearly show a lineage- and stage-specific differentiation block, several studies support the idea that it is a disease that also involves the stem-cell com…”
BackgroundBennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Purification and Characterization of Mouse Hematopoietic Stem Cells
Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,824
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 1×
“This could be applied either in treating bone marrow ex vivo with differentiation agents, followed by bone-marrow transplantation for re-introduction into the patient, or by local therapies, such as instillation into the lung by bronchoscop”
MethodOkuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856 · cited 1×
“Whereas AML1 falls into the category of transcription factors that are involved in the development of haematopoietic cells from haemangioblasts (SCL is another), and disruption of AML1 results in loss of all definitive haematopoiesi”
BackgroundRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., Behm, F. G., Pui, C.-H., Downing, J. R., Gilliland, D. G., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00018-1 · Cited by 1,131
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028 · cited 1×
“However, a recent study has implicated another AML1 family member, RUNX3, in gastric carcinoma”
BackgroundIntercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein
Elliott, G., & O'Hare, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81843-7 · Cited by 972 · cited 1×
“Alternatively, another method could use fusion peptides, such as VP22 or TAT, to facilitate entry into cell”
MethodZhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 1×
“Non-conditional targeted disruption of C/EBPα results in a selective early block in granulocyte maturation, without affecting other haematopoietic lineages, including monocyte”
BackgroundSelf-citationPabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
Self-citationReversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881 · cited 1×
“In fact, several studies indicate that inhibition of E2F might be the most crucial target of C/EBPα in the induction of granulocytic differentiatio”
BackgroundMiyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872 · cited 1×
“Initial attention on AML1 was focused on the nature of its translocation product, and the role of this protein in both myeloid (t(8;21) and AML1/Evi1) and lymphoid (t(12;21) leukaemia”
BackgroundHeparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis
Roberts, R., Gallagher, J., Spooncer, E., Alien, T. D., Bloomfield, F., & Dexter, T. M. (1988) · Nature · doi:10.1038/332376a0 · Cited by 807
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
Wechsler, J., Greene, M., McDevitt, M. A., Anastasi, J., Karp, J. E., Le Beau, M. M., & Crispino, J. D. (2002) · Nature Genetics · doi:10.1038/ng955 · Cited by 760 · cited 1×
“A recent study reported that every paediatric patient that was analysed — with acute megakaryoblastic leukaemia associated with Down's syndrome — harboured mutations in GATA1 , whereas other M7 AML samples did no”
ResultNuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Self-citationMultilineage gene expression precedes commitment in the hemopoietic system.
Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth, C., & Enver, T. (1997) · Genes & Development · doi:10.1101/gad.11.6.774 · Cited by 729
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704 · cited 1×
“So far, AML1 has been associated with the AML FAB subtype M0, the t(8;21) subtype of AML M2 and with TEL–AML1 fusions found in a significant percentage of pre-B-cell AL”
MethodMiyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., & Torbett, B. E. (1999) · Science · doi:10.1126/science.283.5402.682 · Cited by 624
The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo
Wang, Q., Stacy, T., Miller, J. D., Lewis, A. F., Gu, T.-L., Huang, X., Bushweller, J. H., Bories, J.-C., Alt, F. W., Ryan, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81389-6 · Cited by 621
Core-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569 · cited 1×
“The mechanism of AML1 function and its gene targets are still not well understoo”
BackgroundDiversification of haematopoietic stem cells to specific lineages
Orkin, S. H. (2000) · Nature Reviews Genetics · doi:10.1038/35049577 · Cited by 565 · cited 10×
“As described above, most patients with AML that have mutations in PU.1 or C/EBPα do not have chromosome translocations such as t(8;21), t(15;17) or Inv16.”
BackgroundInfluentialThe transcriptional control of hematopoiesis [see comments]
Shivdasani, R., & Orkin, S. (1996) · Blood · doi:10.1182/blood.v87.10.4025.bloodjournal87104025 · Cited by 560 · cited 9×
“C/EBPα M2 with t(8;21) No mutation; downregulation at RNA level”
BackgroundInfluentialThe t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530 · cited 1×
“So far, AML1 has been associated with the AML FAB subtype M0, the t(8;21) subtype of AML M2 and with TEL–AML1 fusions found in a significant percentage of pre-B-cell AL”
MethodFamilial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
Nichols, K. E., Crispino, J. D., Poncz, M., White, J. G., Orkin, S. H., Maris, J. M., & Weiss, M. J. (2000) · Nature Genetics · doi:10.1038/73480 · Cited by 515 · cited 1×
“Mutations in transcription factors that abrogate these interactions have been implicated in human diseas”
BackgroundPreudhomme, C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0990 · Cited by 501
Radomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466
Self-citationMiyamoto, T., Weissman, I. L., & Akashi, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7521 · Cited by 465
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Self-citationNegative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459 · cited 1×
“1 function to direct early progenitor cells towards erythroid and megakaryocytic differentiatio”
BackgroundSelf-citationRekhtman, N., Radparvar, F., Evans, T., & Skoultchi, A. I. (1999) · Genes & Development · doi:10.1101/gad.13.11.1398 · Cited by 454 · cited 1×
“1 function to direct early progenitor cells towards erythroid and megakaryocytic differentiatio”
BackgroundHematopoietic regulators: redundancy or subtlety?
Metcalf, D. (1993) · Blood · doi:10.1182/blood.v82.12.3515.3515 · Cited by 453
Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440 · cited 1×
“For example, analysis of mouse models of Aml1 – Eto indicates that a second genetic pathway, in addition to the fusion protein alone, is require”
Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321298 · Cited by 431 · cited 1×
“It will be important to confirm that these same techniques can be used in studies of gene-knockout animals and in leukaemia models, in which the expression of the markers that are used to isolate these progenitors might be affected — initial studies seem to support their us”
BackgroundMyeloid or Lymphoid Promiscuity as a Critical Step in Hematopoietic Lineage Commitment
Miyamoto, T., Iwasaki, H., Reizis, B., Ye, M., Graf, T., Weissman, I. L., & Akashi, K. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00201-0 · Cited by 415
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Self-citationOsato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R., & Darlington, G. J. (1996) · Genes & Development · doi:10.1101/gad.10.7.804 · Cited by 387
Christy, R. J., Kaestner, K. H., Geiman, D. E., & Lane, M. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2593 · Cited by 385 · cited 1×
“Zhang, unpublished observations), that the regulation of human and mouse C/EBPα are differen”
BackgroundPU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Zhang, P., Zhang, X., Iwama, A., Yu, C., Smith, K. A., Mueller, B. U., Narravula, S., Torbett, B. E., Orkin, S. H., & Tenen, D. G. (2000) · Blood · doi:10.1182/blood.v96.8.2641 · Cited by 368 · cited 1×
“This relative increase in expression or function of one of these lineage-specific transcription factors then directs differentiation along a specific lineage by means of the mechanisms described abov”
BackgroundSelf-citationSasaki, K., Yagi, H., Bronson, R. T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T., & Komori, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12359 · Cited by 368 · cited 1×
“cgi?l=12400"> Cbfβ -knockout mice are almost identica”
BackgroundNerlov, C., Querfurth, E., Kulessa, H., & Graf, T. (2000) · Blood · doi:10.1182/blood.v95.8.2543 · Cited by 366 · cited 1×
“1 function to direct early progenitor cells towards erythroid and megakaryocytic differentiatio”
BackgroundLaskey, R. A., Fairman, M. P., & Blow, J. J. (1989) · Science · doi:10.1126/science.2683076 · Cited by 361
Fairbairn, L. J., Cowling, G. J., Reipert, B. M., & Dexter, T. M. (1993) · Cell · doi:10.1016/0092-8674(93)90462-y · Cited by 358 · cited 1×
“, intrinsically (as described in 'stochastic' models”
C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4
Wang, H., Iakova, P., Wilde, M., Welm, A., Goode, T., Roesler, W. J., & Timchenko, N. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00366-5 · Cited by 355
Weiss, M. J., Yu, C., & Orkin, S. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1642 · Cited by 354 · cited 1×
“It had previously been thought that the amino-terminal transactivation domain was not essential for haematopoiesi”
BackgroundHemopoietic stem cell differentiation
Till, J. E., & McCulloch, E. A. (1980) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(80)90009-8 · Cited by 340
Smith, L., Hohaus, S., Gonzalez, D., Dziennis, S., & Tenen, D. (1996) · Blood · doi:10.1182/blood.v88.4.1234.bloodjournal8841234 · Cited by 332
Self-citationAML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
Nucifora, G., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.1.1.bloodjournal8611 · Cited by 324
E2F Repression by C/EBPα Is Required for Adipogenesis and Granulopoiesis In Vivo
Porse, B. T., Pedersen, T. Å., Xu, X., Lindberg, B., Wewer, U. M., Friis-Hansen, L., & Nerlov, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00516-5 · Cited by 317
BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
Perrotti, D., Cesi, V., Trotta, R., Guerzoni, C., Santilli, G., Campbell, K., Iervolino, A., Condorelli, F., Gambacorti-Passerini, C., Caligiuri, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng791 · Cited by 313
DeKoter, R. P., Walsh, J. C., & Singh, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4456 · Cited by 296 · cited 1×
“1 seems to be required for the development of early multipotential myeloid precursor”
BackgroundFlodby, P., Barlow, C., Kylefjord, H., Åhrlund-Richter, L., & Xanthopoulos, K. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24753 · Cited by 293 · cited 1×
“Both hepatocytes and type II alveolar lung cells undergo hyperproliferation in C/Ebpα-knockout animal”
BackgroundGombart, A. F., Hofmann, W.-K., Kawano, S., Takeuchi, S., Krug, U., Kwok, S. H., Larsen, R. J., Asou, H., Miller, C. W., Hoelzer, D., et al. (2002) · Blood · doi:10.1182/blood.v99.4.1332 · Cited by 293
Hohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5830 · Cited by 284
Self-citationDimerization with PEBP2β protects RUNX1/AML1 from ubiquitin–proteasome‐mediated degradation
Huang, G., Shigesada, K., Ito, K., Wee, H., Yokomizo, T., & Ito, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.723 · Cited by 283 · cited 7×
“Favourable t(15;17), Inv(16), t(8;21) t(15;17), Inv(16) and t(8;21), or C/EBPα mutation without FLT3-ITD or adverse cytogenetics”
BackgroundInfluentialWestendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.322 · Cited by 270
Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2862 · Cited by 263
c-Myc Is a Critical Target for C/EBPα in Granulopoiesis
Johansen, L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., & Tenen, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3789-3806.2001 · Cited by 263
Self-citationSeagroves, T. N., Krnacik, S., Raught, B., Gay, J., Burgess-Beusse, B., Darlington, G. J., & Rosen, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.12.1917 · Cited by 253 · cited 1×
“, other studies have implicated the role of C/EBPβ in normal breast developmen”
BackgroundVangala, R. K., Heiss-Neumann, M. S., Rangatia, J. S., Singh, S. M., Schoch, C., Tenen, D. G., Hiddemann, W., & Behre, G. (2003) · Blood · doi:10.1182/blood-2002-04-1288 · Cited by 245
Self-citationHeterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
Self-citationMcDevitt, M. A., Shivdasani, R. A., Fujiwara, Y., Yang, H., & Orkin, S. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6781 · Cited by 227 · cited 8×
“C/EBPα M2 with t(8;21) No mutation; downregulation at RNA level”
BackgroundInfluentialActivation of the erythropoietin receptor promoter by transcription factor GATA-1.
Zon, L. I., Youssoufian, H., Mather, C., Lodish, H. F., & Orkin, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10638 · Cited by 221 · cited 1×
“Although in vivo autoregulation remains to be shown, tissue-culture studies indicate that most, if not all, of these factors — including GATA1 (Ref”
Background(1995) · PubMed · Cited by 206
Self-citationPedersen, T. Å., Kowenz-Leutz, E., Leutz, A., & Nerlov, C. (2001) · Genes & Development · doi:10.1101/gad.209901 · Cited by 196
Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci2887 · Cited by 187 · cited 1×
“For example, the ability of all- trans retinoic acid (ATRA) to induce differentiation of ACUTE PROMYELOCYTIC LEUKAEMIA (APL) cells might be mediated by C/EBP factors — most notably, C/EBPβ and C/EBP&epsi”
Backgroundc-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
Self-citationNerlov, C., & Ziff, E. B. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00106.x · Cited by 175
Mice Defective in Two Apoptosis Pathways in the Myeloid Lineage Develop Acute Myeloblastic Leukemia
Traver, D., Akashi, K., Weissman, I. L., & Lagasse, E. (1998) · Immunity · doi:10.1016/s1074-7613(00)80587-7 · Cited by 173 · cited 1×
“Another possibility is that such cooperating mutations disrupt cell-death induction pathways, which are also important in AM”
Backgroundde Guzman, C. G., Warren, A. J., Zhang, Z., Gartland, L., Erickson, P., Drabkin, H., Hiebert, S. W., & Klug, C. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5506-5517.2002 · Cited by 171 · cited 2×
“The t(12;21) of acute lymphoblastic leukemia results in a TEL–AML1 gene fusion.”
BackgroundMcBindall—A Better Name for CCAAT/Enhancer Binding Proteins?
McKnight, S. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00543-8 · Cited by 170 · cited 1×
“This is particularly true for C/EBPα, which works through multiple mechanisms to activate p21, inhibit E2F and inhibit CDK functio”
BackgroundWang, X., Scott, E., Sawyers, C. L., & Friedman, A. D. (1999) · Blood · doi:10.1182/blood.v94.2.560 · Cited by 166
Friedman, A. D., & McKnight, S. L. (1990) · Genes & Development · doi:10.1101/gad.4.8.1416 · Cited by 162
Zhang, D., Hohaus, S., Voso, M. T., Chen, H.-M., Smith, L. T., Hetherington, C. J., & Tenen, D. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_14 · Cited by 155
Self-citationIn vivo requirements for GATA‐1 functional domains during primitive and definitive erythropoiesis
Shimizu, R., Takahashi, S., Ohneda, K., Engel, J. D., & Yamamoto, M. P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5250 · Cited by 154 · cited 1×
“, but these findings are compatible with a recent report that showed a role for the amino-terminal region in transgenic rescue studies in vivo”
ResultReddy, V. A., Iwama, A., Iotzova, G., Schulz, M., Elsasser, A., Vangala, R. K., Tenen, D. G., Hiddemann, W., & Behre, G. (2002) · Blood · doi:10.1182/blood.v100.2.483 · Cited by 152
Self-citationVisvader, J. E., Crossley, M., Hill, J., Orkin, S. H., & Adams, J. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.634 · Cited by 151 · cited 1×
“It had previously been thought that the amino-terminal transactivation domain was not essential for haematopoiesi”
BackgroundAutoregulation of the Human C/EBPα Gene by Stimulation of Upstream Stimulatory Factor Binding
Timchenko, N., Wilson, D. R., Taylor, L. R., Abdelsayed, S., Wilde, M., Sawadogo, M., & Darlington, G. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1192 · Cited by 148
Sposi, N. M., Zon, L. I., Carè, A., Valtieri, M., Testa, U., Gabbianelli, M., Mariani, G., Bottero, L., Mather, C., & Orkin, S. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6353 · Cited by 145 · cited 1×
“Some data indicate that GATA1 might function in a cell-cycle-dependent manne”
BackgroundDichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation
Burel, S. A., Harakawa, N., Zhou, L., Pabst, T., Tenen, D. G., & Zhang, D.-E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5577-5590.2001 · Cited by 142
Self-citationInhibition of hematopoiesis by competitive binding of transcription factor PU.1
Voso, M. T., Burn, T. C., Wulf, G., Lim, B., Leone, G., & Tenen, D. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.7932 · Cited by 141
Self-citationCynthia A., C. A., Younes, P., Laucirica, R., & Rosen, J. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1887 · Cited by 139 · cited 1×
“In addition, overexpression of a shorter, dominant-negative form of C/EBPβ — analogous to the shorter dominant-negative form of C/EBPα found in AML cells — has been reported in human breast cancer specimen”
BackgroundHematopoiesis : a developmental approach
Zon, L. I. (2001) · Oxford University Press eBooks · Cited by 136
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view
Schimmer, A. D., Hedley, D. W., Penn, L. Z., & Minden, M. D. (2001) · Blood · doi:10.1182/blood.v98.13.3541 · Cited by 135 · cited 1×
“Another possibility is that such cooperating mutations disrupt cell-death induction pathways, which are also important in AM”
BackgroundDown-regulation and antiproliferative role of C/EBPalpha in lung cancer.
Halmos, B., Huettner, C. S., Kocher, O. N., Ferenczi, K., Karp, D. D., & Tenen, D. G. (2002) · PubMed · Cited by 135
Self-citationZhang, P., Iwama, A., Datta, M. W., Darlington, G. J., Link, D. C., & Tenen, D. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1173 · Cited by 130
Self-citationUnique molecular and cellular features of acute myelogenous leukemia stem cells
Jordan, C. T. (2002) · Leukemia · doi:10.1038/sj.leu.2402446 · Cited by 129
Regulation of the PU.1 gene by distal elements
Li, Y., Okuno, Y., Zhang, P., Radomska, H. S., Chen, H.-M., Iwasaki, H., Akashi, K., Klemsz, M. J., McKercher, S. R., Maki, R. A., et al. (2001) · Blood · doi:10.1182/blood.v98.10.2958 · Cited by 110 · cited 1×
“1 in vivo , underscoring the importance of autoregulation of these factor”
BackgroundSelf-citationLegraverend, C., Antonson, P., Flodby, P., & Xanthopoulos, G. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.8.1735 · Cited by 107 · cited 1×
“Zhang, unpublished observations), that the regulation of human and mouse C/EBPα are differen”
BackgroundKogan, S. C., Brown, D. E., Shultz, D. B., Truong, B.-T. H., Lallemand-Breitenbach, V., Guillemin, M.-C., Lagasse, E., Weissman, I. L., & Bishop, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.531 · Cited by 107
CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia
Truong, B.-T. H. (2003) · Blood · doi:10.1182/blood-2002-05-1374 · Cited by 103 · cited 1×
“For example, the ability of all- trans retinoic acid (ATRA) to induce differentiation of ACUTE PROMYELOCYTIC LEUKAEMIA (APL) cells might be mediated by C/EBP factors — most notably, C/EBPβ and C/EBP&epsi”
BackgroundExpression of the AML-1 Oncogene Shortens the G1Phase of the Cell Cycle
Strom, D. K., Nip, J., Westendorf, J. J., Linggi, B., Lutterbach, B., Downing, J. R., Lenny, N., & Hiebert, S. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3438 · Cited by 100
Cantor, A. B., Katz, S. G., & Orkin, S. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4268-4279.2002 · Cited by 95 · cited 1×
“cgi?l=161882">FOG ), are crucial to regulation of the differentiation of erythroid versus megakaryocytic cell”
BackgroundUse of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBP
Iwama, A., Zhang, P., Darlington, G. J., McKercher, S. R., Maki, R., & Tenen, D. G. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.12.3034 · Cited by 91
Self-citationAnderson, K. L., Smith, K. A., Perkin, H., Hermanson, G., Anderson, C.-G., Jolly, D. J., Maki, R. A., & Torbett, B. E. (1999) · Blood · doi:10.1182/blood.v94.7.2310.419k34_2310_2318 · Cited by 89
Transcription factors, translocations, and leukemia
Nichols, J., & Nimer, S. (1992) · Blood · doi:10.1182/blood.v80.12.2953.2953 · Cited by 87 · cited 1×
“Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle.”
BackgroundDifferential regulation of the human and murine CD34 genes in hematopoietic stem cells
Okuno, Y., Iwasaki, H., Huettner, C. S., Radomska, H. S., Gonzalez, D. A., Tenen, D. G., & Akashi, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092027799 · Cited by 81 · cited 1×
“Although inbred mice have been incredibly useful in studying shared aspects of human and mouse haematopoiesis, it should be emphasized that there are some subtle but significant differences between human and mouse haematopoietic gene regulatio”
BackgroundSelf-citationInduction of granulocytic differentiation by 2 pathways
Zhang, P., Nelson, E., Radomska, H. S., Iwasaki-Arai, J., Akashi, K., Friedman, A. D., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v99.12.4406 · Cited by 78
Self-citationLoss of PU.1 Expression Following Inhibition of Histone Deacetylases
Laribee, R. N., & Klemsz, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5160 · Cited by 64 · cited 1×
“For example, the ability of all- trans retinoic acid (ATRA) to induce differentiation of ACUTE PROMYELOCYTIC LEUKAEMIA (APL) cells might be mediated by C/EBP factors — most notably, C/EBPβ and C/EBP&epsi”
BackgroundVegesna, V., Takeuchi, S., Hofmann, W.-K., Ikezoe, T., Tavor, S., Krug, U., Fermin, A. C., Heaney, A., Miller, C. W., & Koeffler, H. P. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00150-3 · Cited by 54
PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1
Garrett-Sinha, L. A., Dahl, R., Rao, S., Barton, K. P., & Simon, M. C. (2001) · Blood · doi:10.1182/blood.v97.9.2908 · Cited by 52
AML1 stimulates G1 to S progression via its transactivation domain
Bernardin, F., & Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205447 · Cited by 51
Guan, Y., & Hogge, D. E. (2000) · Leukemia · doi:10.1038/sj.leu.2401975 · Cited by 50
Schuster, C., Forster, K., Dierks, H., Elsässer, A., Behre, G., Simon, N., Danhauser-Riedl, S., Hallek, M., & Warmuth, M. (2003) · Blood · doi:10.1182/blood-2002-01-0043 · Cited by 43 · cited 1×
“However, inhibition of cell proliferation and induction of differentiation genes are not always correlated, at least in some granulocytic cell lines; it is possible to inhibit C/Ebpα-induced differentiation of mouse 32D granulocytic cells without inhibiting C/Ebpα-mediated inhibition of cell proliferatio”
BackgroundTranscription Factors: Normal and Malignant Development of Blood Cells
Horiguchi‐Yamada, J. (2001) · International Journal of Hematology · doi:10.1007/bf02982077 · Cited by 41
Collins, S. J., Ulmer, J., Purton, L. E., & Darlington, G. (2001) · Blood · doi:10.1182/blood.v98.8.2382 · Cited by 32
Metcalf, D., Lindeman, G. J., & Nicola, N. A. (1995) · Blood · doi:10.1182/blood.v85.9.2364.bloodjournal8592364 · Cited by 31
C/EBPε −/− mice: increased rate of myeloid proliferation and apoptosis
Verbeek, W., Wächter, M., Lekstrom-Himes, J. A., & Koeffler, H. (2001) · Leukemia · doi:10.1038/sj.leu.2401995 · Cited by 26
Just, U., Friel, J., Heberlein, C., Tamura, T., Baccarini, M., Tessmer, W., Klingler, K., & Ostertag, W. (1993) · Growth Factors · doi:10.3109/08977199308991589 · Cited by 22
Transcription factors. Normal and malignant development of blood cells
(2001) · Platelets · doi:10.1080/09537100120078359 · Cited by 15
Leroy, H., Roumier, C., Grardel, N., Macintyre, E. A., Lepelley, P., Fenaux, P., & Preudhomme, C. (2002) · Blood · doi:10.1182/blood.v99.10.3848 · Cited by 12
Molecular Aspects of Myeloid Stem Cell Development
Wolff, L., & Perkins, A. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9 · Cited by 7
AML1 and AML1 Fusion Protein AML1-ETO in Myeloid Gene Regulation and Leukemogenesis
Zhang, D., Burel, S. A., Zhou, L., Hetherington, C. J., & Yuan, Y. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0391 · Cited by 5 · cited 1×
“, and that the effect of AML1–ETO on C/EBPα expression could differ between human AML and mouse model”
BackgroundNerlov, C., Tenen, D. G., & Graf, T. (2001) · Oxford University Press eBooks · doi:10.1093/oso/9780195124507.003.0033 · Cited by 5
Self-citationMyeloid Transcription Factors and Development
Tenen, D. G. (2001) · Oxford University Press eBooks · doi:10.1093/oso/9780195124507.003.0037 · Cited by 4
Self-citationAML1 is required for megakaryocytic maturation in adult hematopoiesis
市川, 幹. (2003) · Medical Entomology and Zoology · Cited by 3
Research works printed but not linked: 2
- Zhang, P. et al. C/EBPα deficiency blocks granulocytic differentiation at the common myeloid progenitor stage in both adult and fetal liver myelopoiesis. Blood 98, 792a (2001).
- Duprez, E. A., Koch, H. & Tenen, D. G. C/EBPβ is an important target of PML–RARA during ATRA induced differentiation of APL cells. Blood 98, 833a (2001).
Cited by
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Levine, J. H., Simonds, E. F., Bendall, S. C., Davis, K. L., Amir, E.-A. D., Tadmor, M. D., Litvin, O., Fienberg, H. G., Jager, A., Zunder, E. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.047 · Cited by 2,303
“Arising from the disruption of regulated myeloid differentiation (Tenen, 2003), AML results in a disordered developmental hierarchy wherein leukemic stem cells (LSCs) are capable of re-establishing the disease in immunodeficient mice (Bonnet and Dick, 1997).”
InfluentialStem cell gene expression programs influence clinical outcome in human leukemia
Eppert, K., Takenaka, K., Lechman, E. R., Waldron, L., Nilsson, B., van Galen, P., Metzeler, K. H., Poeppl, A., Ling, V., Beyene, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2415 · Cited by 1,041
“In AML, stem cell regulation and differentiation are abnormal; self-renewal is much greater in LSCs than in HSCs, and differentiation is deregulated and highly variable among genetic and morphological subtype”
BackgroundHematopoiesis: a human perspective
Doulatov, S., Notta, F., Laurenti, E., & Dick, J. E. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.01.006 · Cited by 895
“A detailed description of these and other molecular pathways implicated in hematological disorders is the subject of a number of excellent reviews (Tenen, 2003).”
BackgroundFazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., & Bozzoni, I. (2005) · Cell · doi:10.1016/j.cell.2005.09.023 · Cited by 894
Passegué, E., Jamieson, C. H. M., Ailles, L. E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034201100 · Cited by 686
Metadata
- Authors
- Tenen, D. G.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tenen, Daniel G.
- ORCID
- Tenen, Daniel G.
- Venue
- Nature Reviews Cancer
- Published
- 2003-02
- Volume
- 3
- Issue
- 2
- Pages
- 89-101
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2050249118
- Cited by
- 612
- References
- 128
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 16 · 2023: 15 · 2022: 6 · 2021: 23 · 2020: 20 · 2019: 16 · 2018: 17 · 2017: 22 · 2016: 20 · 2015: 18 · 2014: 25 · 2013: 33 · 2012: 27
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- acute myeloid leukemia, cell differentiation, transcription factors, lineage-specific transcription factors, hematopoietic differentiation, transcription factor mutations, solid tumors
- MeSH terms
- Cell Differentiation, Humans, Mutation, Neoplasms, Transcription Factors, Leukemia, Myeloid, Acute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.